Tumor lysis syndrome and mediastinal mass
Tumor lysis syndrome is triggered by rapid malignant cell destruction following chemotherapy, immunotherapy, or radiation and is usually seen in leukemias and lymphomas. It leads to the release of intracellular contents causing metabolic disturbances such as hyperuricemia, hyperkalemia, hyperphospha...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer Medknow Publications
2025-11-01
|
| Saila: | Journal of Pediatric Critical Care |
| Gaiak: | |
| Sarrera elektronikoa: | https://journals.lww.com/10.4103/jpcc.jpcc_134_25 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|